Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?

Current pharmaceutical design - 1 Jan 2022

Tavakol Shima, Tavakol Hani, Alavijeh Mo S, Seifalian Alexander

Abstract excerpt

In 2019, the whole world came together to confront a life-threatening virus named SARS-CoV-2, causing COVID-19 illness. The virus infected the human host by attaching to the ACE2 and CD147 receptors in some human cells, resulting in cytokine storm and death. The new variants of the virus that caused concern are Alpha, Beta, Gamma, Delta, and Epsilon, according to the WHO label. However, Pango lineages designated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to COVID-19
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Share to Vaccines

Share to Viral Envelope Proteins

Source

Identifiers

PMID: 35524677
DOI: 10.2174/1381612828666220506142117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?PMID 35524677Read ↗

An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutionsSemantic proximity Read ↗

Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.Semantic proximity Read ↗

SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape MechanismsSemantic proximity Read ↗

Emerging SARS-CoV-2 Variants Can Potentially Break Set Epidemiological Barriers in COVID-19Semantic proximity Read ↗

The COVID-19 pandemic: a global health crisis.Semantic proximity Read ↗

SARS-CoV-2 variants: Impact on biological and clinical outcomeSemantic proximity Read ↗

Recent updates on COVID-19: A holistic reviewSemantic proximity Read ↗

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance.Semantic proximity Read ↗

SARS-CoV-2: Evolution and Emergence of New Viral Variants.Semantic proximity Read ↗

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseasesSemantic proximity Read ↗

A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.Semantic proximity Read ↗

A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and PreventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.